👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Guardian pharmacy director Steven Cosler buys $148,540 in stock

Published 11/20/2024, 04:07 PM
GRDN
-

Steven D. Cosler, a director at Guardian Pharmacy Services, Inc. (NASDAQ:GRDN), recently purchased 7,000 shares of Class A Common Stock. The shares were acquired at a weighted-average price of $21.22, with the total transaction amounting to approximately $148,540. The purchase occurred on November 19, 2024, and following this transaction, Cosler now holds 17,713 shares directly. The shares were bought in multiple transactions, with prices ranging from $20.81 to $21.70.

In other recent news, Guardian Pharmacy Services has successfully completed its initial public offering (IPO) and an internal reorganization, according to a recent filing with the Securities and Exchange Commission. The retail drug store company, based in Atlanta, issued 8,000,000 shares of Class A common stock, with an additional 1,200,000 shares purchased by underwriters.

The IPO was followed by a corporate reorganization that made Guardian Pharmacy, LLC a wholly-owned subsidiary of Guardian Pharmacy Services. This reorganization was part of a merger agreement involving Guardian Merger Corp., a subsidiary of Guardian Pharmacy Services, and Guardian Pharmacy, LLC. As part of the reorganization, 54,094,132 shares of Class B common stock were issued to former members of Guardian Pharmacy, LLC.

In connection with the IPO, the company entered a Stockholders’ Agreement outlining director nomination rights and voting agreements among founding members. The company's board has been expanded to eight members and reclassified into three classes with staggered terms, and Audit and Compensation Committees have been established.

Finally, Guardian Pharmacy Services adopted a 2024 Equity and Incentive Compensation Plan, effective upon the consummation of the IPO. This plan, along with employment agreements for key executives, outlines the post-IPO compensation structure. These are the latest developments for Guardian Pharmacy Services.

InvestingPro Insights

The recent insider purchase by Steven D. Cosler aligns with several positive indicators for Guardian Pharmacy Services, Inc. (NASDAQ:GRDN). According to InvestingPro data, the company has shown a significant return over the last week, with a 1-week price total return of 8.89%. This short-term momentum is part of a broader trend, as GRDN has demonstrated strong returns over the last month (21.95%) and three months (34.75%).

These positive price movements have brought GRDN's stock to 92.23% of its 52-week high, suggesting investor confidence in the company's prospects. This optimism is further supported by an InvestingPro Tip indicating that net income is expected to grow this year, and analysts predict the company will be profitable this year.

However, it's worth noting that GRDN is currently not profitable over the last twelve months, with a negative P/E ratio of -13.76. Despite this, the company's revenue growth remains strong, with a 16.86% increase in the last twelve months and a 19.66% growth in the most recent quarter.

For investors considering GRDN, it's important to note that the company operates with a moderate level of debt and does not pay a dividend to shareholders. These factors, along with its high Price/Book multiple of 10.53, suggest that GRDN may be positioned for growth rather than immediate income generation.

InvestingPro offers 10 additional tips for GRDN, providing a more comprehensive analysis for those looking to delve deeper into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.